The Director of Drug Supervision and Evaluation at the Food and Drug Administration in Zahedan stated that self-medication with psychiatric drugs can endanger individuals' health; as the type of medication, dosage, and duration of treatment should be determined based on the patient's condition and the doctor's advice.
The Health Risks of Self-Medicating with Psychiatric Drugs
The Director of Drug Supervision in Zahedan warns against the dangers of self-medicating with psychiatric drugs, emphasizing the need for professional guidance in determining treatment. This issue is significant as it highlights public health risks associated with improper medication practices.
👥 Key Players
📰 What Happened
The Director of Drug Supervision in Zahedan issued a warning about the health risks associated with self-medicating using psychiatric drugs, stressing the importance of professional medical guidance for treatment.
- Self-medication can lead to improper dosage and treatment duration, risking individuals' health.
- Professional oversight is essential for safe medication practices.
💡 Why It Matters
📚 Background
Mental health issues are prevalent in Iran, yet access to professional healthcare can be limited, leading many to self-medicate.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%